Glycyrrhizic acid prevents high calorie diet−induced metabolic aberrations despite the suppression of peroxisome proliferator-activated receptor γ expression

Nutrition

Volumn 32, Issue 9, 2016, Pages 995-1001

  Cheng, Hong Sheng ^a   Yaw, Hui Ping ^a   Ton, So Ha ^a   Choy, Siew Mei ^a   Kong, Joana Magdelene Xiao Fang ^a   Abdul Kadir, Khalid ^a  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Adiponectin; Adrenaline; Gluconeogenesis; Glycyrrhizin; Lipoprotein lipase; Metabolic syndrome

Indexed keywords

ADIPONECTIN; CORTICOSTERONE; EPINEPHRINE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCYRRHIZIC ACID; INSULIN; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (PYROPHOSPHATE); ANTIINFLAMMATORY AGENT; FAT INTAKE; SUCROSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; DIET; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DYSLIPIDEMIA; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE METABOLISM; HIGH SUCROSE DIET; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HYPERGLYCEMIA; HYPOADIPONECTINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPID TRANSPORT; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; TREATMENT DURATION; UPREGULATION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DRUG EFFECTS; FAT INTAKE; GLUCONEOGENESIS; SPRAGUE DAWLEY RAT;

ADIPONECTIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; DIET, HIGH-FAT; DIETARY FATS; EPINEPHRINE; GLUCONEOGENESIS; GLYCYRRHIZIC ACID; LIPOPROTEIN LIPASE; MALE; METABOLIC SYNDROME X; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; SUCROSE;

EID: 84964674903     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.02.002     Document Type: Article

References (37)

1. [1] Capurso, C., Capurso, A., From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol 57 (2012), 91–97.
2. [2] Brownlee, M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005), 1615–1625.
3. [3] Murase, T., Mizuno, T., Omachi, T., Onizawa, K., Komine, Y., Kondo, H., et al. Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57 BL/6 J mice. J Lipid Res 42 (2001), 372–378.
4. [4] Sato, A., Kawano, H., Notsu, T., Ohta, M., Nakakuki, M., Mizuguchi, K., et al. Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity. Diabetes 59 (2010), 2495–2504.
5. [5] Boden, G., Chen, X., Stein, T.P., Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280 (2001), E23–E30.
6. [6] Cassuto, H., Kochan, K., Chakravarty, K., Cohen, H., Blum, B., Olswang, Y., et al. Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit. J Biol Chem 280 (2005), 33873–33884.
7. [7] Smith, M.M., Minson, C.T., Obesity and adipokines: effects on sympathetic overactivity. J Physiol 590 (2012), 1787–1801.
8. [8] Ploeger, B., Mensinga, T., Sips, A., Seinen, W., Meulenbelt, J., DeJongh, J., The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modelling. Drug Metab Rev 33 (2001), 125–147.
9. [9] Ko, B.S., Jang, J.S., Hong, S.M., Sung, S.R., Lee, J.E., Lee, M.Y., et al. Changes in components, glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis Fisch, modify insulin sensitizing and insulinotropic actions. Biosci Biotechnol Biochem 71 (2007), 1452–1461.
10. [10] Chia, Y.Y., Ton, S.H., Abdul Kadir, K., Effects of glycyrrhizic acid on peroxisome proliferator-activated receptor gamma (PPARγ), lipoprotein lipase (LPL), serum lipid and HOMA-IR in rats. PPAR Res, 2010, 2010, 530265.
11. [11] Berger, J., Moller, D.E., The mechanisms of action of PPARs. Annu Rev Med 53 (2002), 409–435.
12. [12] Laplante, M., Sell, H., MacNaul, K.L., Richard, D., Berger, J.P., Deshaies, Y., PPAR-γ activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 52 (2003), 291–299.
13. [13] Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 (2001), 2094–2099.
14. [14] Chandramouli, C., Yong, S.T., Lam, Y.L., Ton, S.H., Abdul Kadir, K., Glycyrrhizic improves lipid and glucose metabolism in high-sucrose-fed rats. J Endocrinol Metab 1 (2011), 125–141.
15. [15] Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
16. [16] Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
17. [17] Yang, Z.H., Miyahara, H., Takeo, J., Katayama, M., Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice. Diabetol Metab Syndr, 4, 2012, 32.
18. [18] Itani, S.I., Ruderman, N.B., Schmieder, F., Boden, G., Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkB-α. Diabetes 51 (2002), 2005–2011.
19. [19] Gerich, J.E., Meyer, C., Woerle, H.J., Stumvoll, M., Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24 (2001), 382–391.
20. [20] Nawrocki, A.R., Rajala, M.W., Tomas, E., Pajvani, U.B., Saha, A.K., Trumbauer, M.E., et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281 (2006), 2654–2660.
21. [21] Perri, A., Vizza, D., Lofaro, D., Gigliotti, P., Leone, F., Brunelli, E., et al. Adiponectin is expressed and secreted by renal tubular epithelial cells. J Nephrol 26 (2013), 1049–1054.
22. [22] Matsusue, K., Haluzik, M., Lambert, G., Yim, S.-H., Gavrilova, O., Ward, J.M., et al. Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111 (2003), 737–747.
23. [23] Montague, C.T., Adipose depot-specific effects of PPARγ agonists: a consequence of differential expression of PPARγ in adipose tissue depots?. Diabetes Obes Metab 4 (2002), 356–361.
24. [24] Nye, C.K., Hanson, R.W., Kalhan, S.C., Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat. J Biol Chem 283 (2008), 27565–27574.
25. [25] Eu, C.H., Lim, W.Y., Ton, S.H., Abdul Kadir, K., Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats. Lipids Health Dis, 9, 2010, 81.
26. [26] Fernando, H.A., Chandramouli, C., Rosli, D., Lam, Y.L., Yong, S.T., Yaw, H.P., et al. Glycyrrhizic acid can attenuate metabolic deviations caused by a high-sucrose diet without causing water retention in male Sprague-Dawley rats. Nutrients 6 (2014), 4856–4871.
27. [27] Shimojo, M., Whorwood, C.B., Stewart, P.M., 11 β-hydroxysteroid dehydrogenase in the rat adrenal. J Mol Endocrinol 17 (1996), 121–130.
28. [28] Meyer, C., Stumvoll, M., Welle, S., Woerle, H.J., Haymond, M., Gerich, J., Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans. Am J Physiol Endocrinol Metab 285 (2003), E819–E826.
29. [29] Olswang, Y., Blum, B., Cassuto, H., Cohen, H., Biberman, Y., Hanson, R.W., et al. Glucocorticoids repress transcription of phosphoenolpyruvate carboxykinase (GTP) gene in adipocytes by inhibiting its C/EBP-mediated activation. J Biol Chem 278 (2003), 12929–12936.
30. [30] Tanahashi, T., Mune, T., Morita, H., Tanahashi, H., Isomura, Y., Suwa, T., et al. Glycyrrhizic acid suppresses type 2 11 β-hydroxysteroid dehydrogenase expression in vivo. J Steroid Biochem Mol Biol 80 (2002), 441–447.
31. [31] Lim, W.Y., Chia, Y.Y., Liong, S.Y., Ton, S.H., Abdul Kadir, K., Syed Husain, S.N., Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats. Lipids Health Dis, 8, 2009, 31.
32. [32] Park, M., Lee, J.-H., Choi, J.K., Hong, Y.D., Bae, L.-H., Lim, K.-M., et al. 18 β-glycyrrhetinic acid attenuates anadamide-induced adiposity and high-fat diet induced obesity. Mol Nutr Food Res 58 (2014), 1436–1446.
33. [33] Zhang, L., Keung, W., Samokhvalov, V., Wang, W., Lopaschuk, G.D., Role of fatty acid uptake and fatty acid β-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochim Biophys Acta 1801 (2010), 1–22.
34. [34] Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A.M., Heyman, R.A., Briggs, M., Deeb, S., et al. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15 (1996), 5336–5348.
35. [35] Chintharlappalli, S., Papineni, S., Jutooru, I., McAlees, A., Safe, S., Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor γ agonists in colon cancer cells. Mol Cancer Ther 6 (2007), 1588–1598.
36. [36] Honda, H., Nagai, Y., Matsunaga, T., Saitoh, S., Akashi-Takamura, S., Hayashi, H., et al. Glycyrrhizin and isoliquirtigenin suppress the LPS sensor Toll-like receptor 4/MD-2 complex signalling in a different manner. J Leukoc Biol 91 (2012), 967–976.
37. [37] Honda, H., Nagai, Y., Matsunaga, T., Okamoto, N., Watanabe, Y., Tsuneyama, K., et al. Isoliquirtigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation. J Leukoc Biol 96 (2014), 1087–1100.